We are live on ! Find out more
APOPW

Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW

Delisted

APOPW was delisted on the 3rd of August, 2021.

Back to rankings

2 hedge funds and large institutions have $6K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more capital invested

Capital invested by funds: $2K → $6K (+$4K)

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.47K
2
UBS Group
UBS Group
Switzerland
+$714

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$5K +$1.47K +8,740 +44%
UBS Group
2
UBS Group
Switzerland
$1K +$714 +4,250 New

APOPW Hedge Fund Activity: Q4 2020 in Review

2 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q4 2020, worth a combined $6K — up 200% from $2K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new APOPW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.47K.

  • 2 institutional investors held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q4 2020, up from 1 in Q3 2020.
  • Funds reported $6K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q4 2020, up 200% quarter-over-quarter.
  • 1 fund opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q4 2020 and 0 closed out, a net change of +1 holder.
  • The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs buyer in Q4 2020 was Susquehanna International Group, an estimated $1.47K added.

Based on aggregated 13F filings for Q4 2020.